Contemporary Pediatrics
@ContempPEDS
Followers
211
Following
87
Statuses
3K
Practical Information for Today's Pediatrician
Joined January 2023
In this recap article, we look back to #FDA news in pediatrics for the month of January, 2025! Sign up for our free newsletter to view, and stay informed with our timely news, clinical data, and health care trends. January FDA news:
0
0
0
In another Journal Club article, Marian Freedman and Jon Matthew Farber, MD, note that #IV #acetaminophen with opioids in EA/TEF repair has advantages and disadvantages. Read more:
0
0
0
Colleen Sloan, PA-C, RDN 👩🏼⚕️ provides a look into nutrition's role in #acne care, in this nutrition column. Read how #dairy, chocolate, fried foods, and more can impact acne, and find out what the available data suggests. #Dermatology More:
0
0
0
The submission was supported by data from the phase 3 SAPPHIRE trial and the phase 2 TOPAZ trial, which demonstrated clinically meaningful motor function improvements in patients receiving survival motor neuron (SMN)-targeted treatments. #SMA
0
0
0
New preliminary and positive data has been announced by @Cyclodexpert for Trappsol Cyclo in a sub-study that featured #children from #newborn to 3 years of age with Niemann-Pick Disease Type C1. Data was presented at the @WORLDSymposia in San Diego.
0
0
0
Tina Tan, MD, FAAP, FIDSA, FPIDS, discusses the severity of the current respiratory virus season and stresses the importance of vaccinations to protect against influenza, COVID-19, RSV, and more in this Contemporary Pediatrics video interview. Watch:
0
0
0
In another Journal Club article, Marian Freedman and Jon Matthew Farber, MD, note that #IV #acetaminophen with opioids in EA/TEF repair has advantages and disadvantages. Read more:
0
0
1
In this recap article, we look back to #FDA news in pediatrics for the month of January, 2025! Sign up for our free newsletter to view, and stay informed with our timely news, clinical data, and health care trends. January FDA news:
0
0
0
Diagnosing rare diseases like primary hyperoxaluria type 1 (PH1) can be a complex journey. Jack’s story shows why early detection and specialized care can make all the difference. Read more: #sponsored by Alnylam
0
0
0
In new data reported from LEO Pharma, delgocitinib (Anzupgo) 20 mg / g cream demonstrated efficacy while meeting the primary and all key secondary endpoints in the phase 3 DELTA TEEN trial among adolescents with moderate to severe chronic hand #eczema.
0
0
0
The submission was supported by data from the phase 3 SAPPHIRE trial and the phase 2 TOPAZ trial, which demonstrated clinically meaningful motor function improvements in patients receiving survival motor neuron (SMN)-targeted treatments. #SMA
0
0
0
If you missed it: @Celltrion Inc was awarded @FDA approval for its biosimilar tocilizumab-anoh (Avtozma) (Reference: tocilizumab; Genentech) for several diseases including pJIA and sJIA in patients aged 2 years and older. Read more:
0
0
0
Welcome to a new week! Get caught up with our journal using our weekly review! Click here for a quick recap of our top news from last week:
0
0
0
In a recent study from Moonseong Heo, PhD, Corinna Rea, MD, MPH, Tammy Brady, MD, PhD, et al, found that racial, ethnic disparities exist when counseling on #nutrition, lifestyle, and #weight. Read more:
0
0
0
Welcome to a new week! Get caught up with our journal using our weekly review! Click here for a quick recap of our top news from last week:
0
0
1
A new study presented at the The Society for Maternal-Fetal Medicine’s (SMFM) annual meeting, The Pregnancy Meeting, suggests that #AI can assist clinicians in better detecting congenital #heart defects during routine prenatal #ultrasounds. MORE:
0
0
0
Despite direct guidance and recommendation from the AAP, racial and ethnic disparities persist in the prevalence of hypertension and obesity among pediatric patients, noted the authors. Read more:
0
0
0